Universal Biosensors Inc (UBI) financial statements (2021 and earlier)

Company profile

Business Address 1 CORPORATE AVENUE
VICTORIA, 3178
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments30345152122928
Cash and cash equivalents30345152122928
Restricted cash and investments2000030
Receivables01115055
Inventory, net of allowances, customer advances and progress billings1111101
Inventory1111101
Prepaid expense0001011
Other current assets32321431
Total current assets:37395657648136
Noncurrent Assets
Property, plant and equipment5555699
Intangible assets, net (including goodwill)1616     
Intangible assets, net (excluding goodwill)1616     
Restricted cash and investments5000003
Total noncurrent assets:2622566912
TOTAL ASSETS:63616162709048
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2344834
Accounts payable1011101
Accrued liabilities1222222
Employee-related liabilities1111112
Taxes payable    4  
Deferred revenue3   
Debt     2120
Business combination, contingent consideration, liability22     
Deferred revenue and credits1
Other liabilities3333333
Other undisclosed current liabilities    22 
Total current liabilities:10877132928
Noncurrent Liabilities
Liabilities, other than long-term debt7788338
Deferred revenue and credits5
Deferred revenue1   
Contract with customer, liability55   
Asset retirement obligations3333333
Deferred income tax liabilities34  
Other undisclosed noncurrent liabilities0000440
Total noncurrent liabilities:7788668
Total liabilities:17151414193536
Stockholders' equity
Stockholders' equity attributable to parent, including:45464748515412
Common stock0000000
Additional paid in capital93939393949494
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)(0)
Accumulated deficit(43)(43)(43)(43)(80)(80)(80)
Other undisclosed stockholders' equity attributable to parent(5)(4)(4)(3)3841(0)
Total stockholders' equity:45464748515412
TOTAL LIABILITIES AND EQUITY:63616162709048

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues21229476
Revenue, net6
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1)(1)(1)(1)(0)(1)
Other undisclosed gross profit    (0)  
Gross profit:01118475
Operating expenses(3)(3)(3)(4)(4)(5)(5)
Operating income (loss):(2)(2)(2)(3)442(0)
Nonoperating income (expense)1211(3)(0)(0)
Investment income, nonoperating0000 00
Interest and debt expense    (1)(1)(1)
Income (loss) from continuing operations before equity method investments, income taxes:(2)(1)(1)(3)(0)41(1)
Other undisclosed income from continuing operations before income taxes    111
Income (loss) from continuing operations before income taxes:(2)(1)(1)(3)142(1)
Other undisclosed income (loss) from continuing operations1   (4)  
Net income (loss) available to common stockholders, diluted:(1)(1)(1)(3)(4)42(1)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income (loss):(1)(1)(1)(3)(4)42(1)
Other comprehensive income (loss)0  (0)(0)  
Comprehensive income (loss):(1)(1)(1)(3)(4)42(1)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (0)(0) 0(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(1)(1)(1)(3)(4)42(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: